Edward H. Broekhuizen
Director/Board Member at University of Amsterdam
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jan H. Lindenbergh | M | 80 |
University of Amsterdam
| - |
Cornelius A. J. Herkströter | M | 87 |
University of Amsterdam
| - |
John Kastelein | M | 70 |
University of Amsterdam
| - |
Atzo Nicolaï | M | 64 |
University of Amsterdam
| - |
Johannes J. P. Kastelein | M | 70 |
University of Amsterdam
| - |
Jaap Winter | M | 61 |
University of Amsterdam
| - |
Theo Gevers | M | - |
University of Amsterdam
| - |
Bernardo Miguel Fort Brescia | M | 73 |
University of Amsterdam
| - |
Louise Ottilie Fresco | M | 72 |
University of Amsterdam
| 18 years |
J. J. A. Leenaars | M | 72 |
University of Amsterdam
| - |
Arnoud W. A. Boot | M | 64 |
University of Amsterdam
| 26 years |
Hans Aerts | M | - |
University of Amsterdam
| - |
Steven Perrick | M | 75 |
University of Amsterdam
| - |
Leonard Hoogduin | M | 67 |
University of Amsterdam
| - |
Sjoerd E. Eisma | M | 75 |
University of Amsterdam
| - |
Jaap Goudsmit | M | 73 |
University of Amsterdam
| 35 years |
Paul F. van der Heijden | M | 75 |
University of Amsterdam
| - |
Gerard Nijsten | M | - |
University of Amsterdam
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Boele Oltmans | M | - |
University of Amsterdam
| 4 years |
Reineke Davidsz | F | - |
University of Amsterdam
| 6 years |
Michelle de Rijk | F | - |
University of Amsterdam
| 5 years |
Adri Baan | M | 82 |
University of Amsterdam
| - |
Edo Aalbers | M | - |
University of Amsterdam
| 7 years |
Lennart Verhoef | M | - |
University of Amsterdam
| 5 years |
Mark Schilstra | M | 53 |
University of Amsterdam
| 6 years |
Joannes Gerardus Wijn | M | 55 |
University of Amsterdam
| 3 years |
Balazs Lam | M | - |
University of Amsterdam
| 5 years |
Wim Henk Steenpoorte | M | 60 |
University of Amsterdam
| 6 years |
Jessica Boggia | F | - |
University of Amsterdam
| 4 years |
Frank Baas | M | - |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | 7 years |
Emiel A. A. Roozen | M | 56 |
University of Amsterdam
| 5 years |
Otto van Hermert | M | - |
University of Amsterdam
| 5 years |
Marieke Abcouwer | F | - |
University of Amsterdam
| 6 years |
Mikael Ørum | M | 71 |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | - |
Julia Mensink | F | - |
University of Amsterdam
| 6 years |
Mikael Oerum | M | - |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | 2 years |
Thijs Hovers | M | 49 |
University of Amsterdam
| 6 years |
Christian de Jong | M | - |
University of Amsterdam
| 5 years |
Gavin Goy | M | - |
University of Amsterdam
| 3 years |
Jing Wu | F | 43 |
University of Amsterdam
| 1 years |
Rutger Vos | M | - |
University of Amsterdam
| - |
Arno Wielders | M | - |
University of Amsterdam
| 4 years |
Bastiaan Rogmans | M | - |
University of Amsterdam
| 4 years |
Roos van Gaans | F | - |
University of Amsterdam
| 3 years |
Jacqueline Rijsdijk | F | 68 |
University of Amsterdam
| 5 years |
Ashima Malik | F | - |
University of Amsterdam
| 1 years |
Jurjan Wouda Kuipers | M | 61 |
University of Amsterdam
| 3 years |
Jaska Marianne de Bakker | F | 53 |
University of Amsterdam
| 4 years |
Adam Halasz | M | - |
University of Amsterdam
| 1 years |
Hanna Zwietering | M | - |
University of Amsterdam
| 3 years |
Jan Willem van Tongeren | M | - |
University of Amsterdam
| 3 years |
Elyse De Wit | F | - |
University of Amsterdam
| 4 years |
Jochem Gottmers | M | - |
University of Amsterdam
| 3 years |
Yordanka Ilieva | F | - |
University of Amsterdam
| 4 years |
Gawein Geraedts | M | - |
University of Amsterdam
| 7 years |
Nicolas Hinse | M | - |
University of Amsterdam
| 4 years |
Joost van Dreunen | M | - |
University of Amsterdam
| 5 years |
Sterre Witteveen | F | - |
University of Amsterdam
| 3 years |
Matthijs de Vroome | M | - |
University of Amsterdam
| 3 years |
Gunnar Sturluson | M | 57 |
University of Amsterdam
| 3 years |
Youri Doeleman | M | - |
University of Amsterdam
| 3 years |
Helma Verkouw | F | - |
University of Amsterdam
| 2 years |
Rob Cornelisse | M | 66 |
University of Amsterdam
| - |
Erik Lars Alfred van Emden | M | 76 |
University of Leiden
| 3 years |
Jos Dijsselhof | M | 58 |
University of Amsterdam
| 2 years |
Hubert Verbeek | M | 51 |
University of Amsterdam
| 2 years |
Bastiaan G. Schuttevaer | M | - |
University of Amsterdam
| 1 years |
Hester Borrie | F | 55 |
University of Amsterdam
| 1 years |
Eric Claassen | M | - |
University of Amsterdam
| - |
Michiel Wolfswinkel | M | 61 |
University of Amsterdam
| 4 years |
Annemieke J. M. Roobeek | M | 65 |
University of Amsterdam
| 13 years |
René Kuijten | M | 60 |
University of Amsterdam
| 3 years |
Philip Lambert | M | 78 |
University of Leiden
| 3 years |
Jurgen Leijdekker | M | - |
University of Amsterdam
| 4 years |
Rudolf G. C. van den Brink | M | 76 |
University of Amsterdam
| - |
Jakob Gijsbert de Hoop Scheffer | M | 76 |
University of Leiden
| 4 years |
Karen Maria Alida de Segundo | M | 77 |
University of Leiden
| 3 years |
Josephine Shea | F | - |
University of Amsterdam
| 6 years |
Steinunn Guðjónsdóttir | F | 61 |
University of Amsterdam
| 1 years |
Jaap A. J. Vink | M | 77 |
University of Leiden
| 3 years |
Alexandra Elisabeth Schaapveld | F | 65 |
University of Amsterdam
| - |
Michiel Meeuwissen | M | - |
University of Amsterdam
| 1 years |
Rita de Boer | F | - |
University of Amsterdam
| 6 years |
Pim van Ballekom | M | - |
University of Leiden
| 6 years |
Corné Melissen | M | - |
University of Amsterdam
| 1 years |
Evert-Jan W. van der Slobe | M | 57 |
University of Amsterdam
| 1 years |
Caspar van Grafhorst | M | - |
University of Amsterdam
| 4 years |
Brian van Wachem | M | - |
University of Amsterdam
| 4 years |
Richard Louwers | M | 56 |
University of Amsterdam
| 4 years |
Femke Bos | F | - |
University of Amsterdam
| 1 years |
Michiel von Saher | M | - |
University of Amsterdam
| 12 years |
Stijn Michiel Ehren | M | - |
University of Amsterdam
| 4 years |
Hergen Spits | M | - |
University of Amsterdam
| - |
Frans Middendorff | M | - |
University of Amsterdam
| 3 years |
Valeria Ramaglia | M | - |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | - |
Kees Fluiter | M | - |
Regenesance BV
Regenesance BV Drugstore ChainsRetail Trade Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands. | - |
Hendrik Jan ten Have | M | - |
University of Amsterdam
| 7 years |
Idgar van Kippersluis | M | 52 |
University of Amsterdam
| 6 years |
Susan Poot | F | - |
University of Amsterdam
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Edward H. Broekhuizen
- Personal Network